Carolinas Wealth Consulting’s CRISPR Therapeutics CRSP Stock Holding History

Carolinas Wealth Consulting’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$2.52K	Buy
2021 Q4	–	Sell
2021 Q3	$2K	Hold
2021 Q2	$3K	Hold
2021 Q1	$2K	Hold
2020 Q4	$3K	Buy